[Dr. Anand Verravagu] The President's initiative, the BRAIN initiative,
Brain Research through Advancing Innovative Neurotechnologies,
is, in my opinion, really one of the strongest
awareness campaigns we've had about neuroscience
and the possibilities of treatment.
When I see patients who suffer from
very complicated brain tumors
or advanced Alzheimer's, Parkinson's, or even a severe stroke,
I always think about what it is we'll be able to
treat these patients with in just five or ten years.
Neuroscience is evolving at such a rapid pace.
Being able to unlock some of these mysteries
will really affect all the disease processes.
If we make advancements in traumatic brain injury,
I assure you that we'll be able to glean some of those
advancements and apply them to stroke,
apply them to Alzheimer's, so when I see something
like the BRAIN initiative and the work that the NIH
and DARPA has really put behind something like this,
I'm really inspired to think that hopefully
the American public is now thinking about neuroscience
as sort of the next frontier, and will dedicate resources,
time, effort, and hopefully young students
will be interested in learning more about the brain.
It's incremental. Every step that we take forward
results in some sort of clinical care decision.
Whether we're talking about antibodies that are being developed
on a monthly basis, new radiation systems,
or even new surgical techniques, all of these advancements
really have been focused on translation into the clinical sector,
and I think there might be a time
when we have one really, really big break.
I'm not sure what that's going to be, but that will be something
that everybody will be able to get behind,
and hopefully it will help a lot of different types of patients.
But in the meantime, we're making incremental progress,
and slow and steady will win the race.
But it doesn't hurt to have a few big achievements along the way.
Show transcript | Print transcript
Dr. Anand Veeravagu talks about how Obama's BRAIN initiative will further advancements in research for TBI, stroke, Alzheimer's and other neurological conditions to the arena of clinical care.
Produced by Christian Lindstrom and Justin Rhodes, BrainLine Military.
Anand Veeravagu, MD is a neurosurgeon in training at Stanford University School of Medicine. He is a former White House fellow and special assistant to Secretary of Defense Chuck Hagel. He previously served as chief neurosurgery resident at the Palo Alto Veterans Affairs Hospital.
The contents of BrainLine Military (the “Web Site”), such as text, graphics, images, information obtained from the Web Site’s licensors and/or consultants, and other material contained on the Web Site (collectively, the “Content”) are for informational purposes only. The Content is not intended to be a substitute for medical, legal, or other professional advice, diagnosis, or treatment.
Specifically, with regards to medical issues, always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Web Site. If you think you may have a medical emergency, call your doctor or 911 immediately. The Web Site does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Web Site. Reliance on any information provided by the Web Site or by employees, volunteers or contractors or others associated with the Web Site and/or other visitors to the Web Site is solely at your own risk.